These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8040351)

  • 1. Development and validation of a sensitive and specific radioimmunoassay for the determination of cicaprost in biological samples.
    Hildebrand M; Nieuweboer B; Schütt A
    J Immunoassay; 1994 May; 15(2):171-90. PubMed ID: 8040351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, validation and practical use of a sensitive and specific radioimmunoassay for the determination of iloprost.
    Hildebrand M; Nieuweboer B; Biere H; Klar U; Seemann G; Krause W; Jakobs U
    Eicosanoids; 1990; 3(3):165-9. PubMed ID: 1700724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivation of eptaloprost in animals and man.
    Hildebrand M
    Prostaglandins; 1993 Aug; 46(2):177-89. PubMed ID: 7692471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of 3H-cicaprost in healthy volunteers.
    Hildebrand M; Staks T; Schütt A; Matthes H
    Prostaglandins; 1989 Feb; 37(2):259-73. PubMed ID: 2657866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bioanalytical determinations of Iloprost, a chemically stable PGI2 mimetic, by conventional radioimmunoassay (RIA) and scintillation proximity assay (SPA).
    Hildebrand M; Louton T; Schütt A
    Eicosanoids; 1992; 5(1):5-8. PubMed ID: 1384587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a high throughput direct radioimmunoassay for the quantitative determination of serum and plasma melatonin (N-acetyl-5-methoxytryptamine) in mice.
    Welp A; Manz B; Peschke E
    J Immunol Methods; 2010 Jun; 358(1-2):1-8. PubMed ID: 20363223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of iloprost and cicaprost in mice.
    Hildebrand M
    Prostaglandins; 1992 Nov; 44(5):431-42. PubMed ID: 1281921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and application of a radioimmunoassay of the new progestagen gestodene.
    Nieuweboer B; Tack J; Täuber U; Hümpel M; Wendt H
    Contraception; 1989 Sep; 40(3):313-23. PubMed ID: 2766723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer.
    Vakkuri O; Leppäluoto J; Vuolteenaho O
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):152-7. PubMed ID: 6539551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteers.
    Belch JJ; McLaren M; Lau CS; Mackay IR; Bancroft A; McEwen J; Thompson JM
    Br J Clin Pharmacol; 1993 Jun; 35(6):643-7. PubMed ID: 8329292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of cicaprost in healthy volunteers after oral administration of 5 to 20 micrograms.
    Hildebrand M; Staks T; Nieuweboer B
    Eur J Clin Pharmacol; 1990; 39(2):149-53. PubMed ID: 2253664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of radioimmunoassay for the novel platelet activating factor receptor antagonist, E6123, and its application to pharmacokinetics in laboratory animals.
    Kusano K; Tadano K; Tanaka S; Kagei Y; Ueda M; Miyazawa S; Abe Y; Ida S; Yuzuriha T
    Biol Pharm Bull; 1994 Feb; 17(2):334-9. PubMed ID: 8205134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new radioimmunoassay of thioridazine and its comparison with a high performance liquid chromatographic method and another radioimmunoassay.
    Chakraborty BS; Hawes EM; Rosenthaler J; Midha KK
    Ther Drug Monit; 1987 Jun; 9(2):227-35. PubMed ID: 3617164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised, double-blind study of cicaprost, an oral prostacyclin analogue, in the treatment of Raynaud's phenomenon secondary to systemic sclerosis.
    Lau CS; Belch JJ; Madhok R; Cappell H; Herrick A; Jayson M; Thompson JM
    Clin Exp Rheumatol; 1993; 11(1):35-40. PubMed ID: 8453795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor metastasis inhibition with the prostacyclin analogue cicaprost depends on discontinuous plasma peak levels.
    Schirner M; Kraus C; Lichtner RB; Schneider MR; Hildebrand M
    Prostaglandins Leukot Essent Fatty Acids; 1998 Apr; 58(4):311-7. PubMed ID: 9654405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-species extrapolation of pharmacokinetic data of three prostacyclin-mimetics.
    Hildebrand M
    Prostaglandins; 1994 Nov; 48(5):297-312. PubMed ID: 7531864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of tiamenidine in biological specimens by radioimmunoassay.
    Eckert HG; Baudner S; Weimer KE; Wissmann H
    Arzneimittelforschung; 1981; 31(3):419-24. PubMed ID: 7194666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiatherosclerotic effects of oral cicaprost in experimental hypercholesterolemia in rabbits.
    Braun M; Hohlfeld T; Kienbaum P; Weber AA; Sarbia M; Schrör K
    Atherosclerosis; 1993 Oct; 103(1):93-105. PubMed ID: 8280189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral cicaprost reduces platelet and neutrophil activation in experimental hypercholesterolemia.
    Hohlfeld T; Weber A; Schrör K
    Agents Actions Suppl; 1992; 37():289-96. PubMed ID: 1632303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.